Patents by Inventor Ian Maxwell Shipway
Ian Maxwell Shipway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240042228Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: ApplicationFiled: October 11, 2023Publication date: February 8, 2024Applicant: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Patent number: 11819706Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: GrantFiled: March 22, 2021Date of Patent: November 21, 2023Assignee: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Publication number: 20220176142Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).Type: ApplicationFiled: February 28, 2022Publication date: June 9, 2022Applicant: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
-
Publication number: 20210205631Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: ApplicationFiled: March 22, 2021Publication date: July 8, 2021Applicant: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Patent number: 10981015Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: GrantFiled: December 10, 2018Date of Patent: April 20, 2021Assignee: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Publication number: 20190111273Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: ApplicationFiled: December 10, 2018Publication date: April 18, 2019Applicant: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Patent number: 10183172Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: GrantFiled: November 11, 2013Date of Patent: January 22, 2019Assignee: NEURONETICS, INC.Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Publication number: 20180071544Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).Type: ApplicationFiled: November 16, 2017Publication date: March 15, 2018Applicant: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
-
Patent number: 9849301Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).Type: GrantFiled: January 15, 2014Date of Patent: December 26, 2017Assignee: NEURONETICS, INC.Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
-
Publication number: 20150196772Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).Type: ApplicationFiled: January 15, 2014Publication date: July 16, 2015Applicant: Neuronetics, Inc.Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
-
Publication number: 20150133717Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.Type: ApplicationFiled: November 11, 2013Publication date: May 14, 2015Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
-
Publication number: 20090005729Abstract: Disclosed is a medical infusion device including a dedicated processing unit for detecting abnormal operation of the operation of the device. Specifically, a watchdog controller is employed as an independent monitor of the functioning of microprocessors used in the medical infusion device for controlling things such as RF communication, insulin infusion, and system integrity. Through the use of an independently-powered watchdog control system, the accuracy and reliability of the device is enhanced, resulting in greater assurance to the patient receiving periodic or continuous infusion of a drug.Type: ApplicationFiled: June 27, 2007Publication date: January 1, 2009Applicant: Animas CorporationInventors: Charles Hendrixson, Ian Maxwell Shipway, John Quinlan, Brian J. McLaughlin, Steven Getz
-
Publication number: 20080221521Abstract: Systems and methods for detecting an occlusion may include receiving a signal corresponding to a first force needed to deliver a first material through the tube. Furthermore, the systems and methods may include indicating that an occlusion exists if the first force is greater than a baseline value plus a delta value, the baseline value being assigned a value equal to the force necessary to deliver the first material through the tube in an un-occluded state and the delta value being assigned a value configured to create a desired level of sensitivity.Type: ApplicationFiled: December 28, 2004Publication date: September 11, 2008Inventors: Steven P. Getz, Ian Maxwell Shipway
-
Patent number: 6656148Abstract: A piston-type infusion pump is provided having an improved method of occlusion detection. The infusion pump includes processing circuitry for controlling the drive mechanism to infuse medication to a patient, including a sensor to track the position of the syringe plunger, thereby metering the amount of medication dispensed to the patient. The processing circuitry also includes a force sensor for providing signals indicative of the presence of occlusions along the infusion path. The operation of the drive mechanism causes delivery of medication to the patient. The infusion pump is constructed to be watertight.Type: GrantFiled: May 7, 2002Date of Patent: December 2, 2003Assignee: Animas CorporationInventors: Kusal K. Das, Ian Maxwell Shipway
-
Publication number: 20020128594Abstract: A piston-type infusion pump is provided having an improved method of occlusion detection. The infusion pump includes processing circuitry for controlling the drive mechanism to infuse medication to a patient, including a sensor to track the position of the syringe plunger, thereby metering the amount of medication dispensed to the patient. The processing circuitry also includes a force sensor for providing signals indicative of the presence of occlusions along the infusion path. The operation of the drive mechanism causes delivery of medication to the patient. The infusion pump is constructed to be watertight.Type: ApplicationFiled: May 7, 2002Publication date: September 12, 2002Applicant: Animas CorporationInventors: Kusal K. Das, Ian Maxwell Shipway
-
Patent number: 6423035Abstract: A piston-type infusion pump is provided having an improved method of occlusion detection. The infusion pump includes processing circuitry for controlling the drive mechanism to infuse medication to a patient, including a sensor to track the position of the syringe plunger, thereby metering the amount of medication dispensed to the patient. The processing circuitry also includes a force sensor for providing signals indicative of the presence of occlusions along the infusion path. The operation of the drive mechanism causes delivery of medication to the patient. The infusion pump is constructed to be watertight.Type: GrantFiled: June 18, 1999Date of Patent: July 23, 2002Assignee: Animas CorporationInventors: Kusal K. Das, Ian Maxwell Shipway